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GLUTATHIONE IS RELEASED DURING REPERFUSION 
FROM INFARCTED BUT NOT FROM STUNNED 
MYOCARDIUM 
Terri S. Hoguc. A.A., Ira M. Dauber, 
D. Horwitx, MD., PACC. 
Reactive oxygen metabolitcs may cause injury in stunned (15 
min occlusion) and infarcted (90 min) models of regional canine 
coronary irchcmia and rcperfudon. We examined whether 
myocardirt release of reduced (GSH) or oxidized (GSSG) 
glutothione differs in the two models. GSH is an important 
defense against oxygen mctaholites through oxidation to GSSG. 
GSH and GSSG release is a possible marker of oxygen metabolitc 
iniurv. Anesthetized does underwent 1Smin (N-5) or 90min 
(&Sj left anterior d&ending (LAD) artery ischemia aad 
reperfusion. Plasma from the great cardiac vein (GCV), draining 
the LAD renion. and aorta were arrayed for GSH and GSSG 
hmol/mlh iAd endocordial blood flow by microspheres durin 
&he&r war similar 
Pre- 
in both groups. 
End- 30 min. 
CSH-CCV Ischemia Ischemia 
INFARCTED m iKzzx 
Reperfusion Repexfuaion 
37.4?6.9* 11.0&1.8* 
STUNNED 7.020.9 6.4k0.3 7.6r0.8 5.820.5 
cssc-ccv 
-D 0.55+0.15 0.9220.14 1.7@0.29* 0.8720.27 
STUNNED 0.85kO.35 0.8920.26 0.66kO.18 0.6kO.15 
*pcO.OS STUNNED and pre-lachemia 
GSH and GSSG in the orta were unchanged during ischemia- 
reperfurion in both groups. GSH md GSSG release occurs 
during rcperfusion only from infarcted myocardium. This 
implies a more subtle oxidrtive stress in stunned myocardium, 
and that tissue disruption due to necrosis may be required for 
myocardial GSH or GSSG release. 
TIME COUlRSE OF INFIlTRATION AND DISTRIBUTION OF 
NEUTROPHllS FOLLOWlNC CORONARY ARfERV REPERF USION 
and Robert A Kloner, MD, PhD, FACC. Heart 
Institute of the Ho&al of the Good Samaritan and Univers’w of 
GENERATION OF 
OF ELASTASE BII 
Gainesville, FL. 
Alterations in platelet and neutrophil function durin 
coronary artery thrombosis may influence the extent 
iscbemic injury. Number of circulating platelets and neulrophils, 
neutrophil superoxide radical generation and elastase release weee 
measured in 16 dogs with elect~cal~~~nduce 
tbrombus. These measurements were made before (control) and 
minutes after tbrombus formation, and following thrombo~~is w 
tissue Dlasminonen activator (t-PA). After thrombus formation. 
xlOVm1, PeO.01 vs. control). Neutrophil superoxide radical 
generations increased further 10 18.2k4.7 nmoles/106cells/lO minutes 
and WI 30-43 was detected in large amounts (3OOf345 nmole 
These observations on platelet and neutrophil kinetics su 
consumplion in the thrombus an 
pools in response to myocardial 
indicated by increased superoxi 
large amounts of elastase, may 
injury. 
EFFECTS OF INTERLEUKIN-2 (T CELL GROWTH FACTOR) UPON 
MURINE COXSACRIEVIRUS B3 MXOCARDITIS. 
Chiharu Kishimoto, M.D., Yoshito Kuroki, M.D., Wiroshi 
Gchiai. M.D.. Masahilco Kurokawa. M.D.. Seihachiro Niwavaam. 
M.D., Shigetake Sasayama. M.D..-F.A.CIC.. Toyaam Med. ‘6 
Pharm. univ., Toyama; Japan. 
We have already ahown that the develoDment for severe 
coxaackievirus Bj(CB3) myocarditis is regulated not by B 
cells but by T celle(Cir&latioa 77,645,i988 and 79,ljOO. 
1989). Interleukin-Z(fL-2; T cell nrowth factor) % a T 
cell-derived lvmphokine that stimulates the growth of T 
cells. Therefoie; to text the effects of IL-V 
fected BALB/c mice, recombinant IL-2, sx1o~u. 
upon CB3 in- 
was admini- 
stered subcutaneously daily starting on day O(Crp 2,Exp.I) 
or day 7(Grp 4.Exp.11) for 7 days, respectively. S lenic 
natural killer(NK) cell activity was examined by “C r- 
release assay on day 7 or 10. Gips 1 and 3 were-infected 
controls. 
Survi- Myocard. Lesion 
Grp vora Score(l+ to 44) NK 
2 30 246 1.4+0.7& 0.9kO.6 70.7'19.1*in=8j 
3 18 10 2.120.7 1.920.5 9.4r13.3 (w-4) 
N&ecrosis, again& YAC-1 celle(Eff&tor/&get=50); 
In Exp,f, myocardial virus titers in Grp 2 on day 5(2.0+ 
3.0X10’ p’aque-forming unitr/mg,n~5) wete lower(+0.05) 
than in Grp 1(8.5+5.5x102,nd). In conclusion. IL-2 has 
the potency to limit myoc&disl virus by enb 
tivity in the viremic stage, reaultiag in reduction of 
cardiac pathology. On the ccntrery, it aggravates the 
course and the severity of the dioeaee in the aviremic 
stage, probably by T cell activation. 
